GlassScriptPhysician profile
Sung K Yang
NPI 1275631285
$1,964.69
in general payments reported to CMS, 2019-2025
21 companies · $91.90 in 2025
The $91.90 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $470 · 2020: $389 · 2021: $408 · 2022: $335 · 2023: $231 · 2024: $39.37 · 2025: $91.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $362.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $361.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $461.23 | 2019-2024 | Skyrizi, Mavyret |
| Intercept Pharmaceuticals, INC. | $264.78 | 2019-2022 | |
| Cook Medical LLC | $232.26 | 2022-2025 | Zenith |
| Takeda Pharmaceuticals U.S.A., INC. | $165.58 | 2019-2023 | Entyvio |
| Janssen Biotech, INC. | $139.21 | 2019-2023 | Stelara, Simponi Aria, Simponi |
| Pfizer INC. | $125.14 | 2019-2024 | |
| Gilead Sciences, INC. | $91.58 | 2019-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $84.27 | 2019-2021 | |
| Genzyme Corporation | $73.78 | 2022-2023 | |
| Redhill Biopharma INC. | $51.24 | 2022-2023 | |
| Celgene Corporation | $50.69 | 2022-2023 | Zeposia |
| Organon LLC | $38.44 | 2023 | Renflexis |
| Merck Sharp & Dohme LLC | $29.42 | 2019-2020 | |
| Ambu INC. | $25.27 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $23.06 | 2023 | Dupixent |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $22.63 | 2021 | |
| Micro-Tech Endoscopy USA, INC. | $21.72 | 2021 | |
| Akcea Therapeutics, INC. | $20.91 | 2020 | |
| Braintree Laboratories, INC. | $15.19 | 2019 | |
| Ucb, INC. | $15.13 | 2019 | |
| Nestle Healthcare Nutrition INC. | $13.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sung Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.